Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
NCT07437287 Leucovorin Calcium Advanced biliary tract cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07437287 clinical trial report covering Leucovorin Calcium, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07445191 Triamcinolone Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07445191 clinical trial report covering Triamcinolone, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07448415 Tranexamic Acid Melanosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07448415 clinical trial report covering Tranexamic Acid, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07454837 Bulevirtide Acetate Hepatitis D, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07454837 clinical trial report covering Bulevirtide Acetate, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20260717 XZ022 Stress ulcer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
CTR20260717 clinical trial report covering XZ022, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07454720 Adebrelimab Locally Advanced Rectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07454720 clinical trial report covering Adebrelimab, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07462143 Oxaliplatin Metastatic Colorectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07462143 clinical trial report covering Oxaliplatin, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07459790 Neovasculgen Cystitis, Interstitial Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07459790 clinical trial report covering Neovasculgen, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07459751 Pimurutamab(Shanghai Henlius Biotech, Inc.) Squamous non-small cell lung cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07459751 clinical trial report covering Pimurutamab(Shanghai Henlius Biotech, Inc.), Phase 2/3, endpoints, sponsor, geography, readout timing and develo
Read →
Latest Hotspot
8 min read
ChiCTR2600120404 Butylphthalide Multiple System Atrophy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
ChiCTR2600120404 clinical trial report covering Butylphthalide, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07463313 Cyclophosphamide Thymoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07463313 clinical trial report covering Cyclophosphamide, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07469722 Hydrochlorothiazide Acute congestive heart failure Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07469722 clinical trial report covering Hydrochlorothiazide, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
194
195
196
197
198
>>
1328
>